HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Visual results and complications after retinal reattachment in the acute retinal necrosis syndrome. The influence of operative technique.

Abstract
The authors compare the complications and visual results encountered in a consecutive series of 16 eyes undergoing retinal reattachment surgery for retinal detachment associated with the acute retinal necrosis syndrome. Eight eyes were treated with scleral buckling, vitrectomy, and cryotherapy with or without gas injection. Eight consecutive eyes (with one exception) were treated by the combination of vitrectomy, gas injection and laser photocoagulation with or without primary lensectomy and not subjected to scleral buckling as a primary procedure. The final reattachment rate was 93.8% (15 of 16 eyes) with no significant difference between the primary scleral buckle group (87.5%) and the non-buckle group (100%). Retinal reoperation and complication rates were higher in the primary buckle group and final visual acuities better in the non-buckle group despite comparable preoperative characteristics.
AuthorsM Blumenkranz, J Clarkson, W W Culbertson, H W Flynn, M L Lewis, G M Young
JournalRetina (Philadelphia, Pa.) (Retina) Vol. 9 Issue 3 Pg. 170-4 ( 1989) ISSN: 0275-004X [Print] United States
PMID2595108 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Adolescent
  • Adult
  • Child
  • Female
  • Humans
  • Male
  • Methods
  • Middle Aged
  • Postoperative Complications (physiopathology)
  • Prognosis
  • Retinal Detachment (physiopathology, surgery)
  • Retinal Necrosis Syndrome, Acute (surgery)
  • Syndrome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: